4-Dimensional Model Can Predict Lymph Node Metastases in Breast Cancer
By Elana Gotkine HealthDay Reporter
THURSDAY, May 23, 2024 -- A deep learning model using tumor dynamic contrast-enhanced breast magnetic resonance imaging (MRI) has high sensitivity for identifying lymph node metastasis, according to a study published online April 12 in Radiology: Imaging Cancer.
Dogan S. Polat, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues conducted a retrospective study of patients with newly diagnosed primary invasive breast cancer with known pathologic (pN) and clinical nodal (cN) status who underwent dynamic contrast-enhanced breast MRI. A four-dimensional (4D) convolutional neural network model was developed, integrating temporal information from dynamic image sets. The convolutional layers learned prognostic image features, which were then combined with clinicopathologic measures.
Data were analyzed from 350 female patients. The researchers found that for the 4D hybrid model, the area under the receiver operating characteristic curve, sensitivity, and specificity values were 0.87 and 89 and 76 percent, respectively, for differentiating pN0 from pN+, and 0.79 and 80 and 62 percent, respectively, for differentiating cN0 from cN+.
"We developed and validated a hybrid clinical and 4D MRI-based model that provides individualized prediction of axillary metastasis without the need for dedicated axillary imaging or invasive procedure," the authors write. "Our model is a safe and time-efficient tool, achieving noteworthy results compared with the existing methods."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.